Connecticut Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.07M Sell
5,716
-55
-1% -$18.8K 0.08% 103
2026
Q1
$2.03M Buy
5,771
+10
+0.2% +$3.56K 0.09% 99
2025
Q4
$1.89M Buy
5,761
+572
+11% +$181K 0.08% 104
2025
Q3
$1.46M Buy
5,189
+3,031
+140% +$879K 0.07% 121
2025
Q2
$603K Sell
2,158
-2
-0.1% -$567 0.03% 203
2025
Q1
$673K Sell
2,160
-50
-2% -$14.8K 0.04% 187
2024
Q4
$576K Buy
2,210
+8
+0.4% +$2.37K 0.03% 175
2024
Q3
$710K Sell
2,202
-155
-7% -$50.7K 0.03% 191
2024
Q2
$737K Buy
2,357
+250
+12% +$73.4K 0.04% 182
2024
Q1
$599K Buy
2,107
+43
+2% +$12.6K 0.03% 200
2023
Q4
$595K Buy
2,064
+301
+17% +$82K 0.03% 195
2023
Q3
$474K Buy
1,763
+177
+11% +$44.2K 0.03% 174
2023
Q2
$352K Buy
1,586
+191
+14% +$44.3K 0.02% 186
2023
Q1
$337K Sell
1,395
-56
-4% -$13.7K 0.03% 182
2022
Q4
$381K Buy
1,451
+65
+5% +$17.4K 0.03% 134
2022
Q3
$312K Buy
1,386
+280
+25% +$67.9K 0.03% 139
2022
Q2
$269K Sell
1,106
-20
-2% -$4.9K 0.02% 156
2022
Q1
$272K Buy
1,126
+19
+2% +$4.37K 0.02% 159
2021
Q4
$249K Buy
1,107
+1
+0.1% +$211 0.02% 180
2021
Q3
$235K Buy
1,106
+29
+3% +$6.67K 0.02% 182
2021
Q2
$263K Buy
1,077
+12
+1% +$2.95K 0.02% 163
2021
Q1
$265K Sell
1,065
-900
-46% -$215K 0.02% 138
2020
Q4
$452K Sell
1,965
-42
-2% -$9.68K 0.05% 120
2020
Q3
$510K Sell
2,007
-142
-7% -$35.2K 0.06% 119
2020
Q2
$507K Buy
2,149
+201
+10% +$45.9K 0.06% 88
2020
Q1
$395K Sell
1,948
-49
-2% -$10.7K 0.06% 101
2019
Q4
$482K Buy
1,997
+50
+3% +$11K 0.05% 108
2019
Q3
$377K Buy
1,947
+1
+0.1% +$192 0.05% 116
2019
Q2
$359K Buy
+1,946
New +$348K 0.04% 113

Other funds holding AMGN

Connecticut Wealth Management's AMGN Position: Q2 2026 in Review

Connecticut Wealth Management reduced its Amgen (AMGN) stake by 0.95% in Q2 2026, selling an estimated $18.8K and leaving 5,716 shares worth $2.07M. The position accounts for 0.08% of the portfolio, ranked #103.

Connecticut Wealth Management first reported a position in AMGN in Q2 2019 and has held it in 29 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Connecticut Wealth Management held 5,716 shares of Amgen worth $2.07M as of Q2 2026.
  • Connecticut Wealth Management sold 55 Amgen shares in Q2 2026, an estimated $18.8K.
  • Amgen made up 0.08% of Connecticut Wealth Management's portfolio in Q2 2026, its #103 holding.
  • Connecticut Wealth Management first reported a position in Amgen in Q2 2019 and has held it in 29 quarters since.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Connecticut Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.